EP1978912B1 - Emballage de produits medicaux et equivalent - Google Patents
Emballage de produits medicaux et equivalent Download PDFInfo
- Publication number
- EP1978912B1 EP1978912B1 EP20060841238 EP06841238A EP1978912B1 EP 1978912 B1 EP1978912 B1 EP 1978912B1 EP 20060841238 EP20060841238 EP 20060841238 EP 06841238 A EP06841238 A EP 06841238A EP 1978912 B1 EP1978912 B1 EP 1978912B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- substrate
- products
- product
- blister
- packaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Not-in-force
Links
- 229940127554 medical product Drugs 0.000 title claims description 9
- 238000004806 packaging method and process Methods 0.000 title abstract description 82
- 239000000758 substrate Substances 0.000 claims abstract description 64
- 239000000969 carrier Substances 0.000 claims abstract description 35
- 238000004519 manufacturing process Methods 0.000 claims abstract description 19
- 239000000047 product Substances 0.000 claims description 144
- 239000003814 drug Substances 0.000 claims description 36
- 229940079593 drug Drugs 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 15
- 239000004480 active ingredient Substances 0.000 claims description 13
- 229940127557 pharmaceutical product Drugs 0.000 claims description 9
- 239000002131 composite material Substances 0.000 claims description 8
- 235000015872 dietary supplement Nutrition 0.000 claims description 7
- 238000002955 isolation Methods 0.000 claims 1
- 239000013543 active substance Substances 0.000 abstract description 6
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 239000002994 raw material Substances 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 238000012864 cross contamination Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 230000003442 weekly effect Effects 0.000 description 4
- 208000017667 Chronic Disease Diseases 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 239000000890 drug combination Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000004049 embossing Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000012153 long-term therapy Methods 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000009516 primary packaging Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000019195 vitamin supplement Nutrition 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B5/00—Packaging individual articles in containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, jars
- B65B5/10—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles
- B65B5/101—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles by gravity
- B65B5/103—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles by gravity for packaging pills or tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2200/00—General characteristics or adaptations
- A61J2200/30—Compliance analysis for taking medication
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T83/00—Cutting
- Y10T83/525—Operation controlled by detector means responsive to work
- Y10T83/536—Movement of work controlled
Definitions
- the invention relates to a packaging for pharmaceutical and / or medical products and / or dietary supplements, comprising a substrate equipped with one or more prefabricated, sealed product carriers, each containing one or more isolated products for a defined period of time and with instructions for use - or taking time for the patient is provided, each product carrier in each case only carries products of a specific drug or a specific drug combination in a specific dosage. Furthermore, the invention relates to a method and an apparatus for producing said packages.
- the reliability of compliance with the prescribed pharmaceuticals is of particular importance, which should be supported by the so-called compliance packaging. It has been found that patients more reliably take the medication prescribed to them when one or more and / or different medicaments are arranged side by side or together within a package and the required application or administration times are indicated by calendars and times. For example, in addition to antibiotics, stomach protection preparations are to be taken at the same time. The arrangement or compilation of the drugs by day of the week and time of day makes it easier for the patient to take his prescribed medication reliably, which is particularly important for chronically ill patients of particular importance.
- a receiving space such as a bag, a tubular bag, a nest of a blister pack or the like.
- a receiving space such as a bag, a tubular bag, a nest of a blister pack or the like.
- this is particularly disadvantageous because of the risk of cross-contamination.
- the Products are arranged individually in a compartment of a packaging unit or a nest of blister packaging and packaged in such a way to put together for the patient intended packaging.
- a tablet container with the features of the preamble of claim 1 is known.
- This packaging comprises a substrate on which several isolated products are arranged in sealed product carriers, wherein the dosage of the same active substance or the same combination of active ingredients for the treatment of Parkinson's disease gradually (1st day one tablet, 2nd day one tablet, 3rd day two Tablets, 4th day, three tablets etc.) increases.
- the products are prefabricated in flat blisters. Such blisters have several columns and several lines, for example as 2x5 blisters. This means that the products lie one after the other in sealed nests of the blister tray / blister magazine.
- Locked in this context means that each product within the nest is enclosed on all sides with respect to the environment, so that the products are protected against external influences (mechanical stress or other contaminants, in particular biological or chemical contamination).
- Product carriers separated from the blister tray / blister magazine may contain one or more isolated products. These product carriers are then assembled into a therapy-specific packaging.
- an automated production of such packaging is also possible only with undue effort, since, for example, the separation of individual product carriers from a flat and multi-line blister tray must take place in different directions.
- the packaging described in said EP-font is composed exclusively therapy-specific and automatically only uneconomical to produce.
- each product carrier is part of a rollable and single-web blister pack and the product carriers containing one or more individual products are individually placed on the substrate, the substrate carrying a blister composite or forms, such that a plurality of at least one nest having portions of the product-specific Blistergurtverpackonne each with different isolated products of an active ingredient or a drug combination of one or more manufacturers are applied to the substrate, the product carriers lie with one side on the substrate and on the other side are at least partially covered by a separately supplied cover element.
- a patient-specific packaging is created in a particularly simple and cost-effective manner, since the packaging or the substrate can be assigned one or more different products in a freely selectable amount.
- the packaging allows for each patient freely selectable intake times of the day.
- a decisive advantage lies in the fact that the products are protected from the actual production up to the opening / removal by the patient, since the products lie in the closed product carriers even during and after the arrangement of the patient-individual packing and thus neither mechanical and / or other influences exposed to the environment are still a cross-contamination is to be feared.
- the problems with handling with raw material can therefore be circumvented with this packaging and a sterile assembly can be ensured in a simple manner.
- this also means that the most diverse products can be brought together by different manufacturers from a third party.
- each product carrier is part of a roll-up and single-line blister strip packaging means that the packaging can be produced automatically with simple means, which offers a considerable economic advantage, even with individual packaging (no packaging must be the same to others) and the number of packages produced.
- the packaging according to the invention for the first time ever created a package that combines in a particularly simple manner packaged products from several manufacturers and presented in a patient-individual way.
- exactly one product is arranged in each nest of each blister strip packaging or each section of blister strip packaging.
- each product is optimal and maximally protected.
- the packaging is fully automatic. As a result, a faultless assembly of the products is guaranteed to a packaging, so that incorrect medications are avoided.
- the automatic production also ensures the required cost-effectiveness of the packaging.
- the object is achieved by a method for producing a packaging for pharmaceutical and / or medical products and / or dietary supplements by the following steps: providing a substrate, selecting patient-specific products for a defined period of time, separating pre-assembled, sealed product carriers with the selected, patient-specific Products of roll-up and single-lane Blistergurtverpackonne, each product carrier in each case carries only one or more isolated products of a specific drug or a specific drug combination in a special dosage, automatic positioning and fixing the separated product carriers on the substrate according to the patient-specific specifications, wherein by applying several Sections of the product-specific Blistergurtverpackitch a Blisterverbund is formed, the Blisterverbund from redesignträgem with Produ kten of different manufacturers is formed, in which case a separately supplied lid member is then applied to the substrate on the substrate, so that the or each product carrier is disposed between the lid member and the substrate.
- a device which is characterized in that it comprises a transport element for feeding and discharging individual blanks forming the substrates, receiving places for blister straps in which the products are arranged singly and closed, with a separating means for separating each receptacle the product carrier or the sections of the blister strip is assigned, as well as a placement head for transporting the product carrier or sections separated from the blister strip from a provision position to the dispensing position on the substrate, wherein the device is designed and arranged for feeding separate lid elements.
- the packaging described below is used for patient-specific and individual care of patients with pharmaceutical and / or medical products and / or nutritional supplements.
- the packages are used to hold tablets, dragees or the like.
- Each of the packaging 10 shown is provided or equipped with products 11 for a defined period of time, whereby the individual therapy can last for a very long time, in particular for chronically ill patients.
- the time period as in the embodiments shown may be e.g. be defined as weekly calendar 12. However, monthly or quarter graduations may also be provided on the packages 10.
- the packaging 10 has instructions or information 13 about the actual application or administration times.
- the package 10 comprises a substrate 14, which may be made of cardboard, plastic or other suitable materials.
- the substrate 14 may be flat, ie fan-free or, as in the exemplary embodiments, designed as a folding element 15, for example, to form a so-called wallet packaging.
- the above-mentioned weekly calendar 12 and the information 13 are on the existing preferably as a blank Substrate 14 applied for example by printing, embossing or the like.
- the substrate 14 may each have a perforation or other material weakening in columns and rows in order to simplify a section-wise separation of individual rows and / or columns.
- the product carrier 16 are part of a prefabricated (not explicitly shown) packaging type, in particular a blister (gurt) packaging.
- the prefabricated product carriers 16 are subdivided into sections 17 by separating them from the blister pack, each section 17 having exclusively products 11 of one type or, more precisely, of a specific active substance or a specific combination of active substances with a defined dose.
- each product type is associated with its own product carrier 16.
- the product carriers 16 and / or sections 17 have so-called nests 18 in a manner customary for blister packs, each of which is designed to receive a single product 11.
- each nest 18 is assigned only a single product 11.
- each product 11 of the product carrier 16 is individually identified uniquely with a corresponding optical code.
- the nests 18 are covered by a film 26 or the like, so that they are completely shielded from the environment.
- the individual product carriers 16 or the corresponding sections 17 form a blister composite 19 with the substrate 14.
- Such a blister composite 19 can accordingly have a plurality of sections 17 which are separated from a blister strip, the sections 17 being identical or different (from different blister straps).
- Products 11 may contain from one or more manufacturers.
- the sections 17 are arranged in the form of a matrix with columns and rows according to the administration, wherein a first section 17 one or more separately housed each in a nest 18 copies example of a drug A and a second section 17 one or more separately from each other in a nest 18 encased specimens example of a drug B has.
- the number of rows and the number of columns correspond to an x-times intake on one day and a y-days extending income period.
- the products 11 are individually selected and applied with their respective product carriers 16 on the substrate 14.
- the product carriers 16 or the sections 17 are firmly connected to the substrate 14, for example by heat bonding or the like. Other common attachment means, e.g. by clamping or similar However, they are also possible.
- the substrate 14 itself can serve as a package 10.
- the substrate 14 can also be arranged on or in an outer packaging.
- the substrate 14 or individual parts of the substrate carrying the product carriers 16 with the products 11 are detachably arranged on the outer packaging, so that they can optionally be fed to a preferably electronic dispensing device.
- the package 10 can be combined with measures of the SF and CR described above.
- the substrate 14 may have perforated or pre-punched areas through which the products 11 can be pressed out of the product carriers 16. Again FIG. 6 can be seen, these areas may also be formed as an opening 20.
- the product carriers 16 or the sections 17 rest on the substrate 14 on one side (top or bottom side).
- the product carriers 16 on the other side are at least partially covered by a cover element 21; ie, the product carriers 16 are sandwiched between the cover element 21 and the substrate 14.
- the cover element 21 can also prove openings 22 through which the nests 18 protrude with the products 11 (see in particular FIG FIG. 6 ).
- the package 10 may be formed solely from a substrate 14 having the product carriers 16 disposed thereon or underneath, which embodiment does not fall within the scope of the claims.
- the product carriers 16 can be covered at least partially from one side with cardboard or the like, ie, for example, the substrate 14, or from both sides with cardboard or the like, that is, for example, the substrate 14 and the cover element 21. With such a cover element 21, the product carriers 16 or sections 17 can additionally be fixed and positioned relative to the substrate 14 as well as with each other.
- the package 10 are associated with further information 23, this information 23 attached as a package insert and / or in printed form on the Substrate 14 or other surfaces of the package 10 are arranged.
- information about the individual medicines, the manufacturers or other relevant messages can be removably inserted into a slot or adhered to the package 10 as a leaflet or booklet.
- Information on patient data by way of example, a patient photo may be mentioned here, date of manufacture of the products 11, treating physician, responsible pharmacy, health insurance, producing bottler, distributor, and other necessary for an unmistakable assignment and / or tracing, etc., as well as logos and brands of manufacturers and other information may be printed on the package 10.
- the information 12, 13, 23 may be glued, printed and / or embossed (eg in Braille) or applied in another known manner, the positioning of the information 12, 13, 23 preferably laterally on the substrates 14, the product carriers 16 etc. can be arranged. In addition, for example, for accounting reasons, a consecutive number or the like may be formed on the packaging 10. Also, the package may be attached to 10 media, audio media or other media.
- the information in particular as to the contents of the package 10, may be used for purposes of simple inspection / comparison or e.g. with the recipe data also in coded form e.g. be arranged as a bar code 24 or the like on the package 10.
- all information 12, 13, 23 can be embodied in legibly written form and / or as coding, for example with a luminophore marking.
- the packaging 10 may have an electronic component 25, in particular a memory chip. By means of this device 25 is also a communication to external systems for purposes of control, testing or the like possible.
- packaging 10 may be made manually or automatically.
- a variety of packaging types can be formed, for example a packaging 10 with one and the same product of a manufacturer or a packaging 10 with different products and / or the same products with different dosages of an active ingredient of a manufacturer or a packaging 10 with products from different manufacturers. Any other combinations are also possible. Selected examples are explained below.
- a package 10 is to be taken, which includes a "Wochenration" for a particular patient.
- the packaging FIG. 1 which, for example, represents a possible therapy regimen for a long-term therapy of a chronic illness, stores six different products (A to F) from different manufacturers in different dosages per day.
- the number of products to be taken 11 varies.
- the packaging 10 also carries product instructions (see in particular FIG. 2 ).
- the package 10 according to FIG. 3 are all products 11, which correspond to the drug and the dosage, from a manufacturer.
- information on the medicament itself may alternatively also be indicated on the packaging 10.
- the device 27 has a transport element 28 for transporting individual blanks 29, which form the substrates 14, through the device 27 and past a placement head 30.
- a placement head 30 Preferably, on both sides of the transport element 28, but also on one side receiving spaces 31 are provided for rollers 32, magazines or the like, wherein the rollers 32, magazines or The like preferably carry rolled blister straps for the products 11.
- the placement head 30 is preferably arranged centrally and serves for transporting the product carrier 16 or sections 17 separated from the blister strip from a supply position 33 to the delivery position on the substrate 14.
- the device 27 comprises for each receiving space 31 a release agent by means of which the product carrier 16 or Sections 17 can be separated from the blister strip.
- a printing station 34 is arranged, by means of which the information 12, 13, 23 can be placed on the packaging.
- the placement head 30 has several axes of motion (linear X, Y, Z axis and axis of rotation) and is optionally also linear and / or movable on a circular path and has a controller for automatic and individual execution of the individual manufacturing orders.
- the placement head 30 is preferably connected to an optical reading device in order to check the correct recording of the sections 17 on-line by means of an optical code on the products 11 or the sections 17.
- the device 27 can be networked and even be part of a network and thus, for example, integrated in a logistics system.
- additional control and / or backup steps e.g. be made by reading manufacturing, patient data or other information in the memory chip 25.
- additional control and / or backup steps e.g. be made by reading manufacturing, patient data or other information in the memory chip 25.
- coding 24 further testing or securing steps can be carried out.
- job data (such as a recipe) can be fed directly to the device 27 and implemented by it.
- the method is computer-aided.
- the tablets required for the collection of the desired content and quantity individual packaging can be supplied directly to the distribution center by different manufacturers.
- the distribution center fills the tablets themselves into blister straps so that the tablets are in pre-assembled blister straps for further processing.
- Each blister strip is assigned only a product of a specific active ingredient or a special combination of active ingredients with a special dosage.
- On the blister strip itself only one tablet is assigned to each nest of the blister strip.
- the individual packaging 10 is then assembled from these prefabricated blister straps. For the usual case of pills being filled in blister straps directly at the actual producer of the tablets, the manufacturers deliver the blister straps to the distribution center.
- the distribution center is regionally oriented. This means that the distribution center ensures the assembly and delivery of the individual packaging in a locally defined area.
- the parent distribution center receives the tablets from one or more manufacturers in turn as raw materials and / or packed in blister straps.
- the blister belts and the blister belts filled with the raw material from the distribution center are then delivered either directly to one or more regional distribution centers and / or to a logistics unit, whereby the logistics unit may also be divided into several smaller units.
- the distribution center producing the packages 10 has stockpiled the most common and most widely prescribed products 11 as well as the most widely used combination products. This means that on the basis of detailed information and empirical values, those preparations are needed that are needed for the compilation of individual packages. Even if individual products 11 should not be available in the distribution center, these products 11 can be obtained at short notice from the manufacturer and / or from the higher-level distribution center and / or from the logistics unit.
- the clients can be networked with the distribution center to transfer orders.
- the transfer of information can also be done by conventional means by e-mail or in other usual computer-aided way.
- the incoming orders can be processed automatically and computer-controlled within the distribution center by means of suitable devices 27 by separating the selected products 11 from the stocked blister straps in a predetermined amount and depositing them on a blank 27, substrate 14 or the like supplied to the device 27.
- the resulting patient-specific blister composites or packaging 10 can then still before delivery labeled, coded or otherwise marked and tested, in particular also with electronic aids.
- the distribution center is optionally also connected to the logistics unit and / or the parent distribution center and / or the manufacturers. This connection can be made by conventional means of communication or be ensured by networking. Also, several distribution centers can be networked together. Through the connections, in particular products 11 or blister belts can be supplied as required and / or order-controlled to the or each distribution center producing the packaging 10. Also, the stocking with the relevant products 11 or blister straps within the stations is easy to make sure.
- the produced packaging 10 can be delivered by the distribution center itself or by the logistics unit quasi as a courier service to the client, for example a pharmacy or directly to the patient.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Auxiliary Devices For And Details Of Packaging Control (AREA)
- Packages (AREA)
- Container Filling Or Packaging Operations (AREA)
- Control And Other Processes For Unpacking Of Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Basic Packing Technique (AREA)
- Medicinal Preparation (AREA)
Claims (11)
- Emballage (10) pour produits pharmaceutiques et/ou médicaux (11) et/ou compléments alimentaires, comprenant un substrat (14) garni, pour une période définie, d'un ou plusieurs supports de produits (16) pré-assemblés et fermés, qui contiennent chacun un ou plusieurs produits (11) individualisés, et muni d'instructions relatives à la période d'application ou de prise destinées au patient, chaque support de produits (16) portant exclusivement des produits (11) d'une substance active spéciale ou d'une combinaison spéciale de substances actives selon un dosage particulier, caractérisé en ce que chaque support de produits (16) fait partie d'un emballage blister enroulable et à bande unique et en ce que les supports de produits (16) contenant respectivement un ou plusieurs produits (11) individualisés sont regroupés sur le substrat (14) spécifique à un patient, le substrat (14) portant ou formant un assemblage de blisters (19) de manière telle que plusieurs sections (17) des emballages à bande à blisters spécifiques au produit, présentant au moins une alvéole (18) et portant respectivement des produits (11) individualisés différents d'une substance active ou d'une combinaison de substances actives provenant d'un ou plusieurs fabricants, sont appliquées sur le substrat (14), les supports de produits (16) reposant sur le substrat (14) sur une face et étant recouverts sur l'autre face, au moins partiellement, par un élément de recouvrement (21) rapporté séparément.
- Emballage selon la revendication 1, caractérisé en ce que, dans chaque alvéole (18) de chaque emballage à bande à blisters ou de chaque section (17) des emballages à bande à blisters, est disposé exactement un produit (11).
- Emballage selon la revendication 1 ou 2, caractérisé en ce que les supports de produits (16) ou sections (17) sont reliés fixement au substrat (14).
- Emballage selon l'une des revendications 1 à 3, caractérisé en ce que le substrat (14) est disposé de manière amovible sur un suremballage.
- Emballage selon l'une des revendications 1 à 4, caractérisé en ce qu'est associé au substrat (14) un composant électronique (25) pour stocker des données et/ou informations.
- Procédé de fabrication d'un emballage pour produits pharmaceutiques et/ou médicaux (11) et/ou compléments alimentaires, comprenant les étapes suivantes :- mise à disposition d'un substrat (14),- sélection de produits (11) spécifiques à un patient pour une période définie,- détachement, à partir d'emballages blister enroulables et à bande unique, de supports de produits (16) pré-assemblés et fermés portant les produits (11) sélectionnés spécifiques à un patient, chaque support de produits (16) portant exclusivement un ou plusieurs produits individualisés (11) d'une substance active spéciale ou d'une combinaison spéciale de substances actives selon un dosage spécial,- positionnement automatique et fixation des supports de produits (16) détachés sur le substrat (14) selon les instructions spécifiques au patient, un assemblage de blisters (19) étant formé par l'application de plusieurs sections (17) des emballages à bande à blisters spécifiques à un produit, l'assemblage de blisters (19) étant constitué de supports de produits (16) portant des produits (11) de différents fabricants, un élément de recouvrement (21) rapporté séparément étant alors appliqué sur le substrat (14), de telle sorte que le ou chaque support de produits (16) soit disposé entre l'élément de recouvrement (21) et le substrat (14).
- Procédé selon la revendication 6, caractérisé en ce que le ou chaque support de produits (16) est collé sur le substrat (14).
- Procédé selon la revendication 6 ou 7, caractérisé en ce que les informations de fabrication et/ou de produit sont entrées dans un composant électronique (25) du substrat.
- Procédé selon l'une des revendications 6 à 8, caractérisé en ce que la sélection des produits (11) spécifiques à un patient s'effectue à l'aide d'une prescription.
- Procédé selon l'une des revendications 6 à 9, caractérisé en ce que les informations du patient incluant la médication individuelle respective sont transmises en ligne directement du médecin ou d'un pharmacien ou d'une clinique ou d'autres personnes autorisées à un dispositif (27) destiné à la constitution de l'emballage (10).
- Dispositif de fabrication d'un emballage selon l'une des revendications 1 à 5, comprenant un élément de transport (28) pour l'acheminement et l'évacuation de découpes (29) individuelles formant les substrats (14), des emplacements de réception (31) de bandes à blisters, dans lesquels les produits (11) sont disposés de manière individuelle et fermée, un moyen de séparation étant associé à chaque emplacement de réception (31) pour détacher les supports de produits (16) ou les sections (17) de la bande à blisters, ainsi qu'une tête de mise en place (30) destinée à transporter les supports de produits (16) ou sections (17) détachés de la bande à blisters d'une position de présentation (33) en position de distribution sur le substrat (14), le dispositif étant conçu et configuré pour l'acheminement d'éléments de recouvrement séparés.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL06841238T PL1978912T3 (pl) | 2005-12-21 | 2006-12-21 | Opakowanie dla produktów medycznych i podobnych |
EP20060841238 EP1978912B1 (fr) | 2005-12-21 | 2006-12-21 | Emballage de produits medicaux et equivalent |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20050090355 EP1800645A1 (fr) | 2005-12-21 | 2005-12-21 | Emballage pour produits médicaux et autres |
PCT/EP2006/012644 WO2007077034A1 (fr) | 2005-12-21 | 2006-12-21 | Emballage de produits medicaux et equivalent |
EP20060841238 EP1978912B1 (fr) | 2005-12-21 | 2006-12-21 | Emballage de produits medicaux et equivalent |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1978912A1 EP1978912A1 (fr) | 2008-10-15 |
EP1978912B1 true EP1978912B1 (fr) | 2011-12-07 |
Family
ID=36215478
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20050090355 Withdrawn EP1800645A1 (fr) | 2005-12-21 | 2005-12-21 | Emballage pour produits médicaux et autres |
EP20060841238 Not-in-force EP1978912B1 (fr) | 2005-12-21 | 2006-12-21 | Emballage de produits medicaux et equivalent |
EP20060829905 Not-in-force EP1973511B9 (fr) | 2005-12-21 | 2006-12-21 | Installation de production automatique d'emballages de produits medicaux et/ou pharmaceutiques et/ou de complements alimentaires |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20050090355 Withdrawn EP1800645A1 (fr) | 2005-12-21 | 2005-12-21 | Emballage pour produits médicaux et autres |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20060829905 Not-in-force EP1973511B9 (fr) | 2005-12-21 | 2006-12-21 | Installation de production automatique d'emballages de produits medicaux et/ou pharmaceutiques et/ou de complements alimentaires |
Country Status (12)
Country | Link |
---|---|
US (2) | US8020702B2 (fr) |
EP (3) | EP1800645A1 (fr) |
JP (2) | JP5081835B2 (fr) |
AT (2) | ATE533458T1 (fr) |
AU (2) | AU2006332069B2 (fr) |
CA (2) | CA2634518C (fr) |
DK (2) | DK1973511T3 (fr) |
ES (2) | ES2377347T3 (fr) |
PL (2) | PL1978912T3 (fr) |
PT (2) | PT1973511E (fr) |
RU (2) | RU2008129701A (fr) |
WO (2) | WO2007077034A1 (fr) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10315450B1 (en) | 2006-10-24 | 2019-06-11 | Edge Medical Properties, Llc | System and method for generating an integrated label for container housing multi-script pouches |
US9710866B2 (en) | 2005-09-30 | 2017-07-18 | Edge Medical, Llc | System and method for processing a multiple prescription order |
US20130161207A1 (en) * | 2004-10-01 | 2013-06-27 | Robert A. Luciano, Jr. | Child Resistant Packaging for Multi-Prescription Order |
NL1033807C2 (nl) * | 2007-05-04 | 2008-11-06 | 4C Care & Consultancy B V | Het betreft een herverpak methode van geneesmiddelen in eenheid aflever verpakkingen met behoud van de bescherming en informatie van de oorspronkelijk meervoud verpakking en de mogelijkheid extra informatie toe te voegen. |
US9460948B2 (en) * | 2007-09-04 | 2016-10-04 | Ncr Corporation | Data management |
US9999949B2 (en) * | 2007-09-14 | 2018-06-19 | Seagate Technology Llc | Work piece presentment |
BE1018660A3 (nl) * | 2009-02-19 | 2011-06-07 | Ethilog Sas | Gemarkeerde eenheid en werkwijze voor het vormen van een gemarkeerde eenheid. |
WO2010095102A1 (fr) | 2009-02-19 | 2010-08-26 | Ethilog Sas | Procédé et dispositif de mise en service de marchandises à la pièce |
BE1018659A3 (nl) * | 2009-02-19 | 2011-06-07 | Ethilog Sas | Werkwijze en inrichting voor het commissioneren van stukgoed. |
BE1018661A3 (nl) * | 2009-02-19 | 2011-06-07 | Ethilog Sas | Stukgoedeenheid en werkwijze voor het markeren van een stukgoedeenheid. |
US9798861B2 (en) | 2009-08-12 | 2017-10-24 | Deborah Adler, LLC | Methods, systems and apparatuses for management and storage |
US9643771B2 (en) * | 2009-08-12 | 2017-05-09 | Deborah Adler LLC | Methods, systems and apparatuses for management and storage |
US20130068828A1 (en) * | 2010-05-31 | 2013-03-21 | Onedose Pharma, S.L. | Envelope for single drug dose |
EP2599471B1 (fr) * | 2010-07-29 | 2019-02-27 | Tosho, Inc. | Dispositif de coupe de comprimés |
US20120145585A1 (en) | 2010-12-08 | 2012-06-14 | Id-Con, Llc | Packaging systems and methods |
FR2970647B1 (fr) | 2011-01-21 | 2014-05-02 | Ethilog | Systeme automatise de dose unitaire pour la delivrance nominative de medicaments |
FR2970645B1 (fr) * | 2011-01-21 | 2014-03-28 | Ethilog | Systeme automatise de dose unitaire pour la delivrance nominative de medicaments |
FR2970646B1 (fr) | 2011-01-21 | 2014-03-07 | Ethilog | Systeme automatise de dose unitaire pour la delivrance nominative de medicaments |
US20120234144A1 (en) * | 2011-03-17 | 2012-09-20 | Tormoen Craig C | Methods for sheet registration and shearing |
US10435192B2 (en) | 2011-05-16 | 2019-10-08 | Edge Medical Properties, Llc | Multiple inspection system and method that inspects different medications |
WO2013013108A2 (fr) | 2011-07-19 | 2013-01-24 | Id-Con, Llc | Systèmes et procédés d'emballage |
USD695625S1 (en) | 2012-03-28 | 2013-12-17 | Aventisub Ii Inc. | Package for product |
USD693695S1 (en) | 2012-03-28 | 2013-11-19 | Aventisub Ii Inc. | Package for product |
US8899419B2 (en) | 2012-03-28 | 2014-12-02 | Aventisub Ii Inc. | Package with break-away clamshell |
USD694644S1 (en) | 2012-03-28 | 2013-12-03 | Aventisub Ii Inc. | Clamshell package having blisters |
USD687313S1 (en) | 2012-03-28 | 2013-08-06 | Aventisub Ii Inc. | A-shaped blister card |
USD697813S1 (en) | 2012-03-28 | 2014-01-21 | Aventisub Ii Inc. | Clamshell having blisters received therein |
US8919559B2 (en) | 2012-03-28 | 2014-12-30 | Aventisub Ii Inc. | Package with break-away clamshell |
US8989896B2 (en) * | 2012-04-24 | 2015-03-24 | Arthur E. Brown | High efficiency automated pharmaceutical dispenser |
NO2870072T3 (fr) | 2012-07-05 | 2018-01-20 | ||
SI3284700T1 (sl) | 2012-07-30 | 2020-01-31 | Dosentrx Ltd. | Posoda za vsebovanje in dajanje trdih medicinskih tablet |
EP2754614B1 (fr) * | 2013-01-14 | 2015-06-24 | Edwin Kohl | Installation et procédé destinés au remplissage pour une personne de blisters avec des médicaments |
EP2754615B1 (fr) * | 2013-01-14 | 2015-07-29 | Edwin Kohl | Installation destinée au garnissage pour une personne de blisters avec des médicaments selon des informations de prescription prédéfinies |
US9811637B2 (en) * | 2013-09-04 | 2017-11-07 | Meditab Software Inc. | Medical pill dispensing system |
IL230679A0 (en) * | 2014-01-28 | 2014-08-31 | Astra Prime Inc | A compact multi-drug kit |
US9828158B2 (en) | 2014-04-03 | 2017-11-28 | Toyota Motor Engineering & Manufacturing North America, Inc. | Packaging for visually impaired and blind persons |
IL233295B (en) | 2014-06-22 | 2019-11-28 | Ilan Paz | A control pill dispensing system |
WO2016042457A1 (fr) * | 2014-09-16 | 2016-03-24 | Swisslog Italia S.P.A. | Support pour un médicament, en particulier dans une dose unitaire |
IL238387B (en) | 2015-04-20 | 2019-01-31 | Paz Ilan | Drug dispenser release mechanism |
US10537989B2 (en) * | 2015-05-11 | 2020-01-21 | Sidel Canada | Vertical accumulation in a treatment line |
CN108289793A (zh) | 2015-10-15 | 2018-07-17 | 东森塔克斯公司 | 基于图像识别的剂型分配器 |
US10537493B2 (en) | 2015-10-29 | 2020-01-21 | Satish Poddar | Travel packaging for medications |
WO2017077529A1 (fr) | 2015-11-02 | 2017-05-11 | P.C.O.A. | Contenants de distribution de formes pharmaceutiques orales pouvant être avancés et verrouillés |
EP3269520B1 (fr) * | 2016-07-13 | 2019-02-27 | Evondos Oy | Dispositif pour séparer des emballages de médicaments et distributeur de médicament |
JP6944638B2 (ja) | 2016-09-28 | 2021-10-06 | 株式会社湯山製作所 | 薬剤仕分け装置及び薬剤仕分けシステム |
EP3560850B1 (fr) * | 2018-04-23 | 2020-11-25 | Uhlmann Pac-Systeme GmbH & Co. KG | Unité de transfert et procédé de transfert des plaquettes thermoformées |
EP3560848B1 (fr) * | 2018-04-23 | 2020-12-30 | Uhlmann Pac-Systeme GmbH & Co. KG | Dispositif et procédé de transfert d'emballages-coques |
EP3560846A1 (fr) * | 2018-04-23 | 2019-10-30 | UHLMANN PAC-SYSTEME GmbH & Co. KG | Dispositif et procédé de transfert des emballages-coques |
EP3560849B1 (fr) * | 2018-04-23 | 2021-09-08 | Uhlmann Pac-Systeme GmbH & Co. KG | Unité de transfert et procédé de transfert d'emballages-coques |
EP3560847B1 (fr) * | 2018-04-23 | 2020-11-25 | Uhlmann Pac-Systeme GmbH & Co. KG | Unité de transfert et procédé de transfert des plaquettes thermoformées |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3397671A (en) * | 1965-03-22 | 1968-08-20 | Sparks Corp | Reminder-dispenser device |
US3381808A (en) * | 1966-10-10 | 1968-05-07 | Wallace & Tiernan Inc | Dispensing package |
US3534524A (en) * | 1968-06-21 | 1970-10-20 | Union Camp Corp | Packaging machine |
US3732544A (en) * | 1970-11-25 | 1973-05-08 | D Obland | Computer-controlled article merchandising system for prescription drugs and like articles |
GB1601885A (en) * | 1978-05-30 | 1981-11-04 | Sterwin Ag | Packaging |
JPS60110632A (ja) * | 1983-11-11 | 1985-06-17 | シーケーデイ株式会社 | Ptpシ−トのカ−ル修正装置 |
US4736849A (en) * | 1983-12-19 | 1988-04-12 | Leonard Walter G | Calendar-oriented pill dispenser |
US4617557A (en) * | 1984-11-08 | 1986-10-14 | National Patent Development Corporation | Medication compliance aid for unit dose packaging |
GB8518828D0 (en) * | 1985-07-25 | 1985-08-29 | American Home Prod | Tablet package |
US4958736A (en) * | 1986-03-18 | 1990-09-25 | Gynex, Inc. | Package for oral contraceptive tablet |
JPH0684230B2 (ja) * | 1986-04-28 | 1994-10-26 | 日機電装株式会社 | 定尺位置決め装置 |
NZ231236A (en) * | 1988-11-11 | 1992-07-28 | Manrex Australia Pty Ltd | Assembly for blister package |
US5259500A (en) * | 1991-12-23 | 1993-11-09 | Joseph Alvite | Tape packaging system with removeable covers |
US5329750A (en) * | 1992-11-12 | 1994-07-19 | Bagley Stuart C | Blister packaging machinery |
IT1273843B (it) | 1994-12-05 | 1997-07-11 | Ima Spa | Dispositivo erogatore di un numero viariabile e predeterminabile di compresse, o prodotti farmaceutici similari, riposti entro una confezione entro una confezione blister |
JP2662206B2 (ja) * | 1995-07-20 | 1997-10-08 | 日本イーライリリー株式会社 | 錠剤用容器 |
SE508890C2 (sv) * | 1996-03-14 | 1998-11-16 | Asea Brown Boveri | Manipulator |
IT1286771B1 (it) * | 1996-11-15 | 1998-07-17 | Ima Spa | Dispositivo per il trasferimento di blister da una stazione operativa ad una linea per il confezionamento dei medesimi blister in relativi |
US5752365A (en) * | 1996-12-09 | 1998-05-19 | General Mills, Inc. | Apparatus and methods for inserting premium items |
AT404581B (de) * | 1996-12-20 | 1998-12-28 | Kuchler Fritz | Aufschnittschneidemaschine mit verpackungseinrichtung |
DE19713685A1 (de) * | 1997-04-03 | 1997-11-20 | Karl Herbert Dr Ing Bauer | Blisterstreifen zum Verpacken von Arzneimittel-Tabletten |
IT1311383B1 (it) * | 1999-12-30 | 2002-03-12 | Ima Spa | Metodo e apparecchiatura per la formatura di un nastro alveolato diconfezioni blister in macchine blisteratrici. |
JP4302294B2 (ja) * | 2000-06-13 | 2009-07-22 | シーケーディ株式会社 | Ptpシート及びその製造装置 |
ITBO20000357A1 (it) * | 2000-06-16 | 2001-12-16 | Marchesini Group Spa | Metodo per il trasferimento di confezioni blister e simili alla lineadi alimentazione di una macchina astucciatrice e dispositivo per attua |
GB2366286A (en) * | 2000-08-29 | 2002-03-06 | Almedica Europ Ltd | Blister pack |
DE10147922A1 (de) | 2001-09-28 | 2003-04-30 | Siemens Dematic Ag | Bestückkopf zum Halten von Bauteilen |
US6820401B2 (en) * | 2001-10-31 | 2004-11-23 | International Product Technology, Inc. | Method and apparatus for tensioning cover tape |
ITBO20010677A1 (it) * | 2001-11-06 | 2003-05-06 | Marchesini Group Spa | Dispositivo per il trasferimento di confezioni blister e simili da una stazione di tranciatura alla linea di alimentazione di una macchina c |
ITBO20010713A1 (it) * | 2001-11-23 | 2003-05-23 | Marchesini Group Spa | Metodo e dispositivo per il trasferimento di articoli , in particolare confezioni blister , alla linea di alimentazione di una macchina conf |
ITBO20020002A1 (it) * | 2002-01-08 | 2003-07-08 | Marchesini Group Spa | Apparecchiatura per il reintegro di articoli , in particolare confezioni blister , nella linea di alimentazione di una macchina confezionatr |
US6681935B1 (en) * | 2002-04-02 | 2004-01-27 | Graham L. Lewis | Method of providing a therapeutic regimen and prefabricated container therefor |
US20040148054A1 (en) * | 2003-01-24 | 2004-07-29 | Monty Schwartz | Method and system for packaging and dispensing medication |
EP1481913A1 (fr) * | 2003-05-26 | 2004-12-01 | Dividella AG | Emballage inviolable pour les enfants |
US6922977B2 (en) * | 2003-06-26 | 2005-08-02 | Alloyd Co,. Inc. | Ergonomic blister packaging machine |
DE10350423A1 (de) * | 2003-10-29 | 2005-06-16 | Uhlmann Pac-Systeme Gmbh & Co. Kg. | Stanzstation |
ITBO20030753A1 (it) * | 2003-12-16 | 2005-06-17 | Packservice S R L | Dispositivo per il trasferimento di articoli in configurazione |
DE102004020510B4 (de) | 2004-04-26 | 2007-11-29 | Edwin Kohl | Anlage zur Bestückung von Verpackungseinheiten mit dem verordnungsgemäßen Wochenbedarf von Patienten entsprechenden Medikamenten |
WO2006010086A2 (fr) * | 2004-07-09 | 2006-01-26 | Meadwestvaco Packaging Systems Llc | Machine pour la fermeture de cartons |
DE102004043332A1 (de) * | 2004-09-08 | 2006-03-09 | Iwk Verpackungstechnik Gmbh | Verfahren zum Umsetzen eines Produktes in einer Verpackungsmaschine und Umsetzvorrichtung zur Durchführung des Verfahrens |
-
2005
- 2005-12-21 EP EP20050090355 patent/EP1800645A1/fr not_active Withdrawn
-
2006
- 2006-12-21 RU RU2008129701/14A patent/RU2008129701A/ru not_active Application Discontinuation
- 2006-12-21 JP JP2008546294A patent/JP5081835B2/ja not_active Expired - Fee Related
- 2006-12-21 WO PCT/EP2006/012644 patent/WO2007077034A1/fr active Application Filing
- 2006-12-21 PT PT06829905T patent/PT1973511E/pt unknown
- 2006-12-21 RU RU2008129699/14A patent/RU2008129699A/ru not_active Application Discontinuation
- 2006-12-21 AU AU2006332069A patent/AU2006332069B2/en not_active Ceased
- 2006-12-21 AT AT06829905T patent/ATE533458T1/de active
- 2006-12-21 JP JP2008546293A patent/JP2009520651A/ja active Pending
- 2006-12-21 ES ES06841238T patent/ES2377347T3/es active Active
- 2006-12-21 AT AT06841238T patent/ATE536163T1/de active
- 2006-12-21 DK DK06829905T patent/DK1973511T3/da active
- 2006-12-21 US US12/158,581 patent/US8020702B2/en not_active Expired - Fee Related
- 2006-12-21 US US12/158,532 patent/US7934355B2/en active Active
- 2006-12-21 PL PL06841238T patent/PL1978912T3/pl unknown
- 2006-12-21 EP EP20060841238 patent/EP1978912B1/fr not_active Not-in-force
- 2006-12-21 DK DK06841238T patent/DK1978912T3/da active
- 2006-12-21 PT PT06841238T patent/PT1978912E/pt unknown
- 2006-12-21 EP EP20060829905 patent/EP1973511B9/fr not_active Not-in-force
- 2006-12-21 CA CA 2634518 patent/CA2634518C/fr not_active Expired - Fee Related
- 2006-12-21 AU AU2006332071A patent/AU2006332071B2/en not_active Ceased
- 2006-12-21 CA CA2634524A patent/CA2634524C/fr not_active Expired - Fee Related
- 2006-12-21 WO PCT/EP2006/012642 patent/WO2007077032A1/fr active Application Filing
- 2006-12-21 PL PL06829905T patent/PL1973511T3/pl unknown
- 2006-12-21 ES ES06829905T patent/ES2376744T3/es active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1978912B1 (fr) | Emballage de produits medicaux et equivalent | |
US7055294B1 (en) | Method of providing a therapeutic regimen and prefabricated container therefor | |
EP1794056B1 (fr) | Dispositif d'emballage individuel de comprimes suivant un systeme multidose | |
EP1725208B1 (fr) | Procede et systeme de remplissage automatique de comprimes | |
JP2009520536A5 (fr) | ||
HUE028636T2 (en) | Procedure for connecting an information card to an object packed in a blister pack, an information card, and an information card system | |
DE102005063197A1 (de) | Automatisierte Lageranordnung und Verfahren zum Lagern und Ausgeben von Arzneimitteln | |
DE2920162A1 (de) | Blisterverpackung | |
DE102006016942A1 (de) | System und Verfahren zum Abgeben von Medikamenten aus einer Verpackung | |
EP2754614A1 (fr) | Installation et procédé destinés au remplissage pour une personne de blisters avec des médicaments | |
CA2516047A1 (fr) | Necessaire d'administration de medicaments | |
EP3341303A1 (fr) | Emballage alvéolaire | |
JP2022126879A (ja) | 薬剤仕分け装置及び薬剤仕分けシステム | |
DE60128348T2 (de) | Automatische maschine zum verpacken von festen pharmazeutischen produkten | |
WO2016037923A1 (fr) | Système et procédé de reconditionnement de différents médicaments hors de leurs emballages-coques respectifs d'origine dans des emballages-coques à remplir | |
AT521328B1 (de) | Medikamentenbehälter | |
DE202006015150U1 (de) | System zur automatischen Verpackung von Arzneimitteln | |
EP0637817B1 (fr) | Dispositif et méthode pour la caractérisation des données relatives au contenu d'un emballage | |
DE2608763A1 (de) | Verfahren und einrichtung zum verpacken und verteilen von medikamenten | |
DE102007004152A1 (de) | Vorrichtung und Verfahren zum Befüllen von Patientenblistern | |
EP2393467A1 (fr) | Procédé pour produire un empilement de pochettes servant à conserver et à mettre à disposition des médicaments sous forme stratifiée, modèle de pochette pour produire ledit empilement et utilisation dudit modèle | |
DE102009017869B3 (de) | Verfahren zum individuellen Zusammenstellen von Tabletten sowie Vorrichtung zur Durchführung des Verfahrens | |
DE102017215917A1 (de) | Individuelle Blisterverpackung, Verpackungsmaschine und Verfahren zur Herstellung einer individuellen Blisterverpackung | |
DE202005008656U1 (de) | Vorrichtung zu Individual-Verblisterung von Tabletten | |
EP1801719A1 (fr) | Procédé mis en oeuvre dans un ordinateur, destiné à la distribution de produits pharmaceutiques et médicaux |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080719 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
17Q | First examination report despatched |
Effective date: 20090605 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AVIDIAMED GMBH |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BREU, GERHARD Inventor name: VON BISMARCK, GOTTFRIED Inventor name: STRUB, NIKOLAI |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20111219 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502006010689 Country of ref document: DE Effective date: 20120209 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2377347 Country of ref document: ES Kind code of ref document: T3 Effective date: 20120326 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111207 |
|
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20111207 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111207 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120308 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111207 |
|
REG | Reference to a national code |
Ref country code: PL Ref legal event code: T3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111207 |
|
BERE | Be: lapsed |
Owner name: AVIDIAMED G.M.B.H. Effective date: 20111231 |
|
REG | Reference to a national code |
Ref country code: HU Ref legal event code: AG4A Ref document number: E013276 Country of ref document: HU |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111207 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120407 Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20111231 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120307 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111207 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111207 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111207 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20111231 |
|
26N | No opposition filed |
Effective date: 20120910 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502006010689 Country of ref document: DE Effective date: 20120910 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: HU Payment date: 20121211 Year of fee payment: 7 Ref country code: FI Payment date: 20121219 Year of fee payment: 7 Ref country code: IE Payment date: 20121217 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20121123 Year of fee payment: 7 Ref country code: PT Payment date: 20111219 Year of fee payment: 7 Ref country code: TR Payment date: 20121221 Year of fee payment: 7 Ref country code: IT Payment date: 20121219 Year of fee payment: 7 |
|
REG | Reference to a national code |
Ref country code: HU Ref legal event code: AG4B Ref document number: E013276 Country of ref document: HU |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20121226 Year of fee payment: 7 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20111221 |
|
REG | Reference to a national code |
Ref country code: HU Ref legal event code: AG4B Ref document number: E013276 Country of ref document: HU |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: KOERBER MEDIPAK SYSTEMS GMBH, DE Free format text: FORMER OWNER: AVIDIAMED GMBH, DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: SD Effective date: 20140116 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP Owner name: KORBER MEDIPAK SYSTEMS GMBH, DE Effective date: 20140108 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20140116 AND 20140122 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: PC Ref document number: 536163 Country of ref document: AT Kind code of ref document: T Owner name: KOERBER MEDIPAK SYSTEMS GMBH, DE Effective date: 20140103 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 502006010689 Country of ref document: DE Owner name: KOERBER MEDIPAK SYSTEMS GMBH, DE Free format text: FORMER OWNER: AVIDIAMED GMBH, 20097 HAMBURG, DE Effective date: 20140127 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20140623 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131221 Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140623 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131221 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131222 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131221 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20150327 |
|
REG | Reference to a national code |
Ref country code: PL Ref legal event code: LAPE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131222 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131221 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131221 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 502006010689 Country of ref document: DE Owner name: KOERBER MEDIPAK SYSTEMS GMBH, DE Free format text: FORMER OWNER: KOERBER MEDIPAK SYSTEMS GMBH, 20097 HAMBURG, DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PCOW Free format text: NEW ADDRESS: ANCKELMANNSPLATZ 1, 20537 HAMBURG (DE) |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: CA Effective date: 20160727 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20181219 Year of fee payment: 13 Ref country code: AT Payment date: 20181220 Year of fee payment: 13 Ref country code: DK Payment date: 20181219 Year of fee payment: 13 Ref country code: SE Payment date: 20181219 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20181220 Year of fee payment: 13 Ref country code: FR Payment date: 20181221 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP Effective date: 20191231 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20200101 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 536163 Country of ref document: AT Kind code of ref document: T Effective date: 20191221 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20191221 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191231 Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191222 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191221 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191221 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191231 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20211221 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20211216 Year of fee payment: 16 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 502006010689 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221231 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230701 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221231 |